INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

被引:0
|
作者
Kebir, Sied [1 ,2 ]
Lazaridis, Lazaros [1 ,2 ]
Schmidt, Teresa [1 ,2 ]
Oster, Christoph [1 ,2 ]
Feldheim, Jonas [3 ,4 ]
Pierscianek, Daniela [5 ]
Proescholdt, Martin [6 ]
Hau, Peter [7 ,8 ]
Grosu, Anca-Ligia [9 ]
Krex, Dietmar [10 ]
Sure, Ulrich [11 ]
Scheffler, Bjoern [12 ]
Kleinschnitz, Christoph [1 ,2 ]
Poettgen, Christoph [13 ]
Stuschke, Martin [14 ]
Glas, Martin [1 ,2 ]
机构
[1] Univ Duisburg Essen, Univ Med Essen, Dept Neurol, Essen, Germany
[2] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
[3] Univ Med Essen, Dept Neurol, Essen, Germany
[4] Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
[5] Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany
[6] Univ Regensburg, Dept Neurosurg, Med Ctr, Regensburg, Germany
[7] Univ Hosp Regensburg, Dept Neurol, Regensburg, CA USA
[8] Univ Hosp Regensburg, Wilhelm Sander Neurooncol Unit, Regensburg, CA USA
[9] Med Ctr Univ Freiburg, Dept Radiat Oncol, Freiburg, Germany
[10] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurosurg, Dresden, Germany
[11] Univ Duisburg Essen, Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany
[12] German Canc Res Ctr, Heidelberg, Germany
[13] Univ Med Essen, Dept Radiotherapy, Essen, Germany
[14] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CTNI-65
引用
收藏
页数:2
相关论文
共 50 条
  • [21] FIRST RESULTS OF THE CONCOMITANT PROTOCOL IN NEWLY DIAGNOSED GLIOBLASTOMA AND COMPARISON TO ALTERNATIVE PROTOCOL
    Caroli, M.
    Campanella, R.
    Menghetti, C.
    Zella, S.
    Borsa, S.
    Costa, F.
    De Santis, A.
    Fornari, M.
    Gaini, S.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1124 - 1125
  • [22] TUMOR TREATING FIELDS AND RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY AND EFFICACY RESULTS FROM A PILOT STUDY
    Grossman, Rachel
    Bokstein, Felix
    Blumenthal, Deborah
    Ben Harush, Carmit
    Limon, Dror
    Ram, Zvi
    NEURO-ONCOLOGY, 2018, 20 : 144 - 144
  • [23] PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE plus /- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel
    Nagpal, Seema
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Grossman, Rachel
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 59 - 60
  • [24] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [25] Final results of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Salgado, M. A. Vaz
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    Lopez-Munoz, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S410 - S410
  • [26] Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial
    Giordano, Frank A.
    Brehmer, Stefanie
    Muerle, Bettina
    Welzel, Grit
    Sperk, Elena
    Keller, Anke
    Abo-Madyan, Yasser
    Scherzinger, Elisabeth
    Clausen, Sven
    Schneider, Frank
    Herskind, Carsten
    Glas, Martin
    Seiz-Rosenhagen, Marcel
    Groden, Christoph
    Haenggi, Daniel
    Schmiedek, Peter
    Emami, Bahman
    Souhami, Luis
    Petrecca, Kevin
    Wenz, Frederik
    NEUROSURGERY, 2019, 84 (01) : 41 - 49
  • [27] Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma Clinical article
    Muragaki, Yoshihiro
    Maruyama, Takashi
    Iseki, Hiroshi
    Tanaka, Masahiko
    Shinohara, Chie
    Takakura, Kintomo
    Tsuboi, Koji
    Yamamoto, Tetsuya
    Matsumura, Akira
    Matsutani, Masao
    Karasawa, Katsuyuki
    Shimada, Katsunori
    Yamaguchi, Naohito
    Nakazato, Yoichi
    Sato, Keiki
    Uemae, Youji
    Ohno, Tadao
    Okada, Yoshikazu
    Hori, Tomokatsu
    JOURNAL OF NEUROSURGERY, 2011, 115 (02) : 248 - 255
  • [28] PHASE I/II TRIAL OF HYPERFRACTIONATED CONCOMITANT BOOST PROTON RADIOTHERAPY FOR SUPRATENTORIAL GLIOBLASTOMA MULTIFORME
    Mizumoto, Masashi
    Tsuboi, Koji
    Igaki, Hiroshi
    Yamamoto, Tetsuya
    Takano, Shingo
    Oshiro, Yoshiko
    Hayashi, Yasutaka
    Hashii, Haruko
    Kanemoto, Ayae
    Nakayama, Hidetsugu
    Sugahara, Shinji
    Sakurai, Hideyuki
    Matsumura, Akira
    Tokuuye, Koichi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 98 - 105
  • [29] Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
    Ram, Zvi
    Kim, Chae-Yong
    Hottinger, Andreas F.
    Idbaih, Ahmed
    Nicholas, Garth
    Zhu, Jay-Jiguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Efficacy and Safety of STUPP Regimen Anlotinib for Newly Diagnosed Glioblastoma: A Multicenter, Double-Blind, Randomized Phase II Trial
    Chen, Y.
    Liu, G.
    Sun, P.
    Li, M.
    Yang, X.
    Pan, L.
    Wang, L.
    Hua, Y.
    Zhao, M.
    Liu, Y.
    Ran, J.
    Cai, H.
    Lu, X.
    Hao, J.
    Li, X.
    Zheng, W.
    Liu, Z.
    Lin, S.
    Deng, M.
    Yang, Q.
    Guo, C.
    Li, J.
    Chen, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E223 - E224